Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Liposomal cisplatin in cancer patients with renal failure.

Trial Profile

Liposomal cisplatin in cancer patients with renal failure.

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Sep 2012

At a glance

  • Drugs Cisplatin (Primary) ; Fluorouracil; Folinic acid; Gemcitabine; Paclitaxel
  • Indications Bladder cancer; Gastrointestinal cancer; Non-small cell lung cancer
  • Focus Therapeutic Use
  • Sponsors Regulon
  • Most Recent Events

    • 11 Sep 2012 New trial record
    • 15 Aug 2012 Results from this trial to be published in the Journal of Drug Delivery & Therapeutics, according to a Regulon media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top